Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.80% | -44.44% | -16.88% | -39.88% | -57.47% |
| Total Depreciation and Amortization | 1.30% | -2.95% | -4.30% | -7.16% | -68.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.46% | 30.08% | -12.78% | -17.68% | 158.80% |
| Change in Net Operating Assets | -55.14% | 28.61% | -722.31% | 152.93% | -443.57% |
| Cash from Operations | -40.56% | -48.29% | -80.65% | -41.18% | -74.28% |
| Capital Expenditure | 60.21% | -30.95% | -176.96% | -466.67% | -31.82% |
| Sale of Property, Plant, and Equipment | -- | -- | 1,600.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -312.42% | 264.33% | 22.51% | -311.85% | -561.66% |
| Cash from Investing | -308.13% | 262.98% | 21.90% | -312.06% | -532.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -58.59% | -102.50% | 36.89% |
| Issuance of Common Stock | 24,268.81% | 32.67% | -24.36% | -57.97% | -96.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 54.61% | -64,350.00% | -- | -- | -480.77% |
| Cash from Financing | 3,127.55% | 25.98% | -25.89% | -63.88% | -132.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.94% | 81.39% | -108.81% | -146.73% | -231.49% |